Core Points - The Shanghai Investment Products Index (000102) closed at 7120.52 points, up 0.92%, with a trading volume of 58.14 billion yuan and a turnover rate of 1.12% [1] - Among the index constituents, 33 stocks rose, led by Zhongjin Gold with a 4.15% increase, while 14 stocks fell, with Samsung Medical leading the decline at 1.88% [1] Index Constituents Summary - The top ten constituents of the Shanghai Investment Products Index include: - Yinghui Mining (6.27% weight, 28.51 yuan, 1.82% increase, market cap 757.73 billion yuan) in the non-ferrous metals sector - China Shipbuilding (5.26% weight, 34.93 yuan, 1.58% decrease, market cap 262.87 billion yuan) in the defense industry - Northern Rare Earth (5.01% weight, 45.05 yuan, 0.47% increase, market cap 162.86 billion yuan) in the non-ferrous metals sector - Jiangqi Green Energy (4.99% weight, 18.98 yuan, 1.17% increase, market cap 143.83 billion yuan) in the power equipment sector - Longzhi Aluminum Industry (4.67% weight, 15.97 yuan, 4.04% increase, market cap 341.67 billion yuan) in the non-ferrous metals sector - Sany Heavy Industry (4.48% weight, 20.44 yuan, 0.34% decrease, market cap 186.13 billion yuan) in the machinery sector - China Shenhua (3.91% weight, 41.20 yuan, no change, market cap 818.58 billion yuan) in the coal sector - TBEA (3.86% weight, 22.07 yuan, 2.56% increase, market cap 111.52 billion yuan) in the power equipment sector - Guodian NARI (3.79% weight, 22.19 yuan, 0.18% increase, market cap 178.23 billion yuan) in the power equipment sector - Huayou Cobalt (3.73% weight, 60.51 yuan, 3.97% increase, market cap 114.73 billion yuan) in the non-ferrous metals sector [1] Capital Flow Analysis - The net inflow of main funds into the index constituents totaled 1.055 billion yuan, while speculative funds saw a net outflow of 631 million yuan, and retail investors experienced a net outflow of 424 million yuan [1] - Specific stocks with significant capital flow include: - Huayou Cobalt with a net inflow of 300 million yuan, but speculative and retail outflows of 46.34 million yuan and 25.4 million yuan respectively - China Aluminum with a net inflow of 208 million yuan, but speculative and retail outflows of 70.64 million yuan and 13.7 million yuan respectively - TBEA with a net inflow of 179 million yuan, but speculative and retail outflows of 62.93 million yuan and 11.6 million yuan respectively [2]

Core Viewpoint - Samsung Medical (601567.SH) announced that its wholly-owned subsidiary, Ningbo Aux Intelligent Technology Co., Ltd., has been recommended as a candidate for winning bids in a procurement project by State Grid Corporation of China, with a total expected bid amount of approximately 106.5993 million yuan [1] Group 1 - The subsidiary, Aux Intelligent Technology, participated in the procurement for overhead insulated wires, 10kV transformers, and complete sets of 10kV pole-mounted transformer equipment [1] - The total expected bid amount of approximately 106.5993 million yuan indicates a significant opportunity for the company in the energy sector [1]

证券代码：601567 证券简称：三星医疗 公告编号：临 2025-089 宁波三星医疗电气股份有限公司 关于经营合同预中标的提示性公告 本公司董事会及全体董事保证公告内容不存在虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 本次中标公示媒体是国家电网有限公司电子商务平台，招标人是国网黑龙江省电 力有限公司，其他详细内容请查看国家电网有限公司电子商务平台： https://ecp.sgcc.com.cn/ecp2.0/portal/#/doc/doci-win/2511243069796379_201806050 1171107 二、预中标项目对公司业绩的影响 本次奥克斯智能科技预中标金额约为10,659.93万元，交货时间需根据实际合同要 求确定。上述项目中标后，其合同的履行将对公司的经营工作和经营业绩产生积极的 影响，但不影响经营的独立性。 三、预中标项目风险提示 目前，奥克斯智能科技尚未收到国网黑龙江省电力有限公司及其相关代理机构发 出的中标通知书；合同期限需根据实际合同要求确定，对公司业绩的影响存在不确定 性。敬请广大投资者谨慎决策，注意防范投资风险。 特此公告。 ...

Core Viewpoint - Samsung Medical (601567.SH) announced that its wholly-owned subsidiary, Ningbo Aux Intelligent Technology Co., Ltd. (referred to as "Aux Intelligent Technology"), has been recommended as a candidate for winning bids in a procurement project by State Grid Corporation of China, with an estimated total bid amount of approximately 107 million yuan [1]. Group 1 - The subsidiary Aux Intelligent Technology is involved in the procurement of overhead insulated wires, 10kV transformers, and complete sets of 10kV pole-mounted transformer equipment [1]. - The procurement project is part of the State Grid Corporation's 2025 Northeast Region second joint procurement initiative [1].

Core Viewpoint - Samsung Medical (601567.SH) announced that its wholly-owned subsidiary, Ningbo Aux Intelligent Technology Co., Ltd. (referred to as "Aux Intelligent Technology"), has been recommended as a candidate for winning bids in a procurement project by State Grid Corporation of China, with an estimated total bid amount of approximately 107 million yuan [1]. Group 1 - The subsidiary Aux Intelligent Technology is involved in the procurement of overhead insulated wires, 10kV transformers, and complete sets of 10kV pole-mounted transformer equipment [1]. - The procurement project is part of the State Grid Corporation's 2025 Northeast Region second joint procurement initiative [1].

Core Points - Two companies, Huiyuan Communication and Hualan Group, are undergoing changes in control and will resume trading on November 19, 2025 [2][3] - Aik Shares is planning to issue shares to acquire assets and will be suspended from trading starting November 19, 2025 [5] - ST Zhengping's stock has seen a significant increase of 221.93% from September 1 to November 18, 2025, leading to a suspension for verification [6] - Tianyima plans to acquire 98.5632% of Xingyun Kaiwu for 1.1885 billion yuan and will issue shares to raise up to 155 million yuan [9] Group 1: Control Changes - Huiyuan Communication plans to issue up to 53.65 million shares at 11.37 yuan per share, raising a total of up to 610 million yuan, with the proceeds used for working capital [2] - Hualan Group's actual controllers will transfer a total of 851.13 million shares (5.79% of total shares) to Xutong Investment at a price of 20.41 yuan per share, totaling 174 million yuan [3] Group 2: Suspensions and Resumptions - Aik Shares will be suspended from trading as it plans to issue shares and cash to acquire Dongguan Silicon Xiang Insulation Materials Co., Ltd. [5] - ST Zhengping's stock will be suspended for verification due to its stock price significantly deviating from fundamentals [6] - ST Dongyi has completed its verification work and will resume trading on November 19, 2025 [11] Group 3: Major Asset Restructuring - Tianyima is planning a major asset restructuring by acquiring a majority stake in Xingyun Kaiwu for 1.1885 billion yuan [9] - Meng Tian Home has terminated its asset restructuring and control change plans, leading to its resumption of trading [9] Group 4: Fundraising Activities - Jin An Guo Ji plans to raise up to 1.29995 billion yuan through a private placement for a high-grade copper-clad laminate project [9] - Wan Tong Technology is also planning a private placement to raise up to 920 million yuan for working capital [9]

Group 1 - Shengxin Lithium Energy signed a framework agreement with Huayou Cobalt for the procurement of 221,400 tons of lithium salt products over five years [1] - Wehua New Materials' subsidiary plans to acquire 70% of He Yutai for 154 million yuan [1] - Xiamen Tungsten plans to invest 600 million yuan to establish a wholly-owned subsidiary for a project with an annual production capacity of 50,000 tons of high-performance battery materials [1][2] Group 2 - *ST Songfa's subsidiary signed a shipbuilding contract worth approximately 200-300 million USD for two VLCCs [3] - Hailianxun's stock will resume trading on November 19 after the end of the acquisition request period [5] - Yunnan Energy Investment obtained the development rights for a 25,000 kW wind power project [7] Group 3 - China Resources Double Crane's subsidiary received a drug registration certificate for Oxcarbazepine tablets [8] - Jincheng Pharmaceutical's subsidiary received a CEP certificate for glutathione raw materials [9] - Jinkong Electric plans to transfer 51% of Tongying Thermal Power to an affiliate for 266 million yuan [9] Group 4 - Clean Technology's subsidiary won a bid for a waste incineration power generation project in Thailand with a total investment of up to 4.27 million USD [12] - Tonglian Precision's shareholders set the transfer price for shares at 43.67 yuan each [13] - Hu Nong Commercial Bank's executives collectively purchased 259,100 shares of the company [13] Group 5 - Huatai Medical's subsidiary obtained a medical device registration certificate for polyethylene embolization microspheres [13] - Fosun Pharma's subsidiary's drug registration application was accepted by the National Medical Products Administration [13] - Xianhui Technology signed contracts worth 796 million yuan with multiple subsidiaries of CATL [15] Group 6 - Ningbo Fangzheng signed a strategic cooperation agreement with Huaxiang Qiyuan for the development of various robotic technologies [15] - Ruida Futures' vice president resigned for personal reasons [16] - Samsung Medical is expected to win contracts worth approximately 125 million yuan from the State Grid [17] Group 7 - Tianjin Pharmaceutical's injectable methylprednisolone sodium succinate received registration from Panama's Ministry of Health [19] - Yaxing Anchor Chain plans to invest up to 300 million yuan in a project for deep-sea floating equipment [20] - Zejing Pharmaceutical's clinical trial for ZG006 was approved by the National Medical Products Administration [21] Group 8 - Weiye Co., Ltd. won a bid for a project worth approximately 2.086 billion yuan [23] - Ruimao Tong plans to sell 8.5794 million repurchased shares [25] - Guangge Technology's shareholders plan to reduce their holdings by up to 3.99% [26] Group 9 - Hongsheng Development signed a debt restructuring contract for a total of 2 billion yuan [27][28] - Yatai Co., Ltd. plans to reduce its holdings by up to 1% [30] - Dexin Technology's shareholder plans to reduce its holdings by up to 1% [31] Group 10 - Yaji International's shareholder plans to reduce its holdings by up to 1% [33] - Shenzhen New Star's subsidiary received approval for trial production of a boron trifluoride project [35] - Shengyi Electronics plans to raise up to 2.6 billion yuan through a private placement [36]

证券代码：601567 证券简称：三星医疗 公告编号：临 2025-088 宁波三星医疗电气股份有限公司 关于经营合同预中标的提示性公告 本公司董事会及全体董事保证公告内容不存在虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 宁波三星医疗电气股份有限公司（以下简称"公司"）及下属全资子公司宁波奥克 斯智能科技股份有限公司（以下简称"奥克斯智能科技"）于近日在国网江苏省电力有 限公司 2025 年第二次配网物资协议库存公开招标采购项目、国网安徽电力 2025 年第 二次物资协议库存公开招标采购项目中被推荐为中标候选人，预计合计中标总金额约 为 12,529.07 万元，现将预中标情况公告如下： 一、国家电网项目预中标的主要内容 1、国网江苏省电力有限公司2025年第二次配网物资协议库存公开招标采购项目 国家电网有限公司于近日在其电子商务平台（http://ecp.sgcc.com.cn）公告"国网 江苏省电力有限公司2025年第二次配网物资协议库存公开招标采购推荐的中标候选 人公示"（招标编号：1025AB），奥克斯智能科技为中标候选人。 https://ecp.sgcc. ...

Group 1 - Samsung Medical (601567.SH) announced that it and its wholly-owned subsidiary, Ningbo Aux Intelligent Technology Co., Ltd. (referred to as "Aux Intelligent Technology"), have been recommended as candidates for winning bids in two public procurement projects by State Grid Jiangsu Electric Power Co., Ltd. and State Grid Anhui Electric Power Co., Ltd. for the year 2025 [1] - The total expected bid amount for these projects is approximately 125 million yuan [1]

Core Insights - Samsung Medical (601567.SH) announced that it and its wholly-owned subsidiary, Ningbo Aux Intelligent Technology Co., Ltd., have been recommended as candidates for winning bids in two public procurement projects by State Grid Jiangsu Electric Power Co., Ltd. and State Grid Anhui Electric Power Co., Ltd. for 2025 [1] Group 1 - The total expected bid amount for the projects is approximately 125 million yuan [1]